共 50 条
- [41] Incidence and Impact of Oligometastatic Disease Detected on 18F-Fluciclovine PET/CT in Biochemically Recurrent Prostate Cancer [J]. JOURNAL OF NUCLEAR MEDICINE, 2021, 62
- [42] Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on 18F-Fluciclovine PET/CT Guidance [J]. JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (08): : 1089 - 1096
- [43] Detection of Additional Primary Neoplasms on 18F-Fluciclovine PET/CT in Patients with Primary Prostate Cancer [J]. JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (05): : 713 - 719
- [46] PREDICTORS OF POSITIVE LESIONS IN 18F-FLUCICLOVINE (AXUMIN) PET/CT [J]. JOURNAL OF UROLOGY, 2020, 203 : E1103 - E1103
- [47] PREOPERATIVE 18F-FLUCICLOVINE PET/CT FINDINGS MAY BE PREDICTIVE OF POST-OPERATIVE PROSTATE-SPECIFIC ANTIGEN (PSA) IN PATIENTS WITH HIGH RISK PROSTATE CANCER [J]. JOURNAL OF UROLOGY, 2020, 203 : E1026 - E1026
- [49] Pictorial essay: incidental findings on 18F-Fluciclovine PET/CT scan [J]. Clinical and Translational Imaging, 2021, 9 : 189 - 198
- [50] 18F-Fluciclovine PET/CT performance in biochemical recurrence of prostate cancer: a systematic review [J]. Prostate Cancer and Prostatic Diseases, 2021, 24 : 997 - 1006